EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Sodium Zirconium Cyclosilicate in the Therapeutic Management of Hyperkalemia: A Systematic Review of Efficacy and Safety

Esteban Zavaleta-Monestel, José Andrés Castro-Gamboa, Luis Guillermo Herrera-Jiménez, Sebastián Arguedas-Chacón, Jeaustin Mora-Jiménez, Kevin Cruz-Mora, Sofía Granados-Romero, José Miguel Chaverri-Fernandez

Kidney and Dialysis · 13.03.2026 · 6 (1) · 19

DOI: 10.3390/kidneydial6010019 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Kidney and Dialysis, online erschienen am 13.03.2026. Verfasst von Esteban Zavaleta-Monestel und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study is to evaluate the efficacy and safety of sodium zirconium cyclosilicate in the treatment of hyperkalemia in adult patients based on the available scientific evidence.

Methods

A systematic review of randomized controlled trials evaluating SZC in adult patients with hyperkalemia was conducted, including populations with chronic kidney disease and heart failure and patients undergoing hemodialysis. Outcomes assessed included serum potassium reduction, achievement and maintenance of normokalaemia, and adverse events.

Results

Seven randomized controlled trials were included. SZC produced a rapid and significant reduction in serum potassium, with reductions of up to 1.28 mmol/L within 48 h and onset of action observed as early as 1–4 h. Across studies, 63–92% of patients achieved normokalaemia within 24–48 h, and maintenance therapy sustained normokalaemia for up to 28 days and longer in selected populations. The most frequently reported adverse events were mild-to-moderate edema and constipation, while hypokalemia was infrequent (

Zitieren

APA

Zavaleta-Monestel, E., Castro-Gamboa, J. A., Herrera-Jiménez, L. G., Arguedas-Chacón, S., Mora-Jiménez, J., Cruz-Mora, K., Granados-Romero, S., & Chaverri-Fernandez, J. M. (2026). Sodium Zirconium Cyclosilicate in the Therapeutic Management of Hyperkalemia: A Systematic Review of Efficacy and Safety. Kidney and Dialysis, 6(1), 19. https://doi.org/10.3390/kidneydial6010019

Vancouver

Zavaleta-Monestel E, Castro-Gamboa JA, Herrera-Jiménez LG, Arguedas-Chacón S, Mora-Jiménez J, Cruz-Mora K, et al. Sodium Zirconium Cyclosilicate in the Therapeutic Management of Hyperkalemia: A Systematic Review of Efficacy and Safety. Kidney and Dialysis. 2026;6(1):19. doi:10.3390/kidneydial6010019

BibTeX
@article{ZavaletaMonestel2026,
  author = {Zavaleta-Monestel, Esteban and Castro-Gamboa, José Andrés and Herrera-Jiménez, Luis Guillermo and Arguedas-Chacón, Sebastián and Mora-Jiménez, Jeaustin and Cruz-Mora, Kevin and Granados-Romero, Sofía and Chaverri-Fernandez, José Miguel},
  title = {Sodium Zirconium Cyclosilicate in the Therapeutic Management of Hyperkalemia: A Systematic Review of Efficacy and Safety},
  journal = {Kidney and Dialysis},
  year = {2026},
  volume = {6},
  number = {1},
  pages = {19},
  doi = {10.3390/kidneydial6010019}
}
Kostenlos starten →